Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control

NCT01841008 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Pigmentation Disorders
Vitiligo

Interventions

DRUG: Protopic
DRUG: Placebo : Diprobase

Sponsor

Centre Hospitalier Universitaire de Nice